Nobutaka Nishimura
About
Nobutaka Nishimura is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Nobutaka Nishimura has authored 46 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 11 papers in Urology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nobutaka Nishimura's work include Bladder and Urothelial Cancer Treatments (32 papers), Urinary and Genital Oncology Studies (29 papers) and Urological Disorders and Treatments (10 papers). Nobutaka Nishimura is often cited by papers focused on Bladder and Urothelial Cancer Treatments (32 papers), Urinary and Genital Oncology Studies (29 papers) and Urological Disorders and Treatments (10 papers). Nobutaka Nishimura collaborates with scholars based in Japan and United Kingdom. Nobutaka Nishimura's co-authors include Kiyohide Fujimoto, Makito Miyake, Shunta Hori, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Tomomi Fujii, Yosuke Morizawa, Daisuke Gotoh and Yuki Oda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Urology and Cancers.
In The Last Decade
Nobutaka Nishimura
45 papers receiving 237 citations
Peers
Nobutaka Nishimura
Zachary Kozel United States
P. Bigot France
A. Jurczok Germany
C. Michiels France
Rohit Chahal United Kingdom
Kyle Rose United States
Joanna Chorbińska Poland
Elisabete Barbosa Portugal
Filippo Sogni Italy
Ali̇ Şahi̇n Türkiye
Citations per year, relative to Nobutaka Nishimura Nobutaka Nishimura (= 1×)
peers
Zachary Kozel
Countries citing papers authored by Nobutaka Nishimura
Since
Specialization
Citations
This map shows the geographic impact of Nobutaka Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutaka Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutaka Nishimura more than expected).
Fields of papers citing papers by Nobutaka Nishimura
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nobutaka Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutaka Nishimura. The network helps show where Nobutaka Nishimura may publish in the future.
Co-authorship network of co-authors of Nobutaka Nishimura
This figure shows the co-authorship network connecting the top 25 collaborators of Nobutaka Nishimura. A scholar is included among the top collaborators of Nobutaka Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobutaka Nishimura. Nobutaka Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Miyake, Makito, Nobutaka Nishimura, Yuki Oda, et al.. (2025). Real‐World Analysis of the Enfortumab Vedotin‐Ineligible criTeriA Assessment in Treatment‐Naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma. International Journal of Urology. 32(6). 761–763.
2.
Shimizu, Takuto, Makito Miyake, Nobutaka Nishimura, et al.. (2024). Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. Cancers. 16(4). 841–841.
3.
Nishimura, Nobutaka, Makito Miyake, Kota Iida, et al.. (2024). Treatment patterns and prognosis in patients with Bacillus Calmette–Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis. World Journal of Urology. 42(1). 185–185.
4.
Miyake, Makito, Nobutaka Nishimura, Tatsuki Miyamoto, et al.. (2023). Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting Agent. SHILAP Revista de lepidopterología. 2023. 1–5.
5.
Miyake, Makito, Nobutaka Nishimura, Tomomi Fujii, & Kiyohide Fujimoto. (2023). Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, andBCG ‐treated disease. International Journal of Urology. 30(11). 944–957.
6.
Miyamoto, Tatsuki, Makito Miyake, Nobutaka Nishimura, et al.. (2023). Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study. International Journal of Urology. 30(5). 473–481.
7.
Nishimura, Nobutaka, Makito Miyake, Tatsuki Miyamoto, et al.. (2023). Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study. International Journal of Urology. 30(12). 1112–1119.
8.
Miyake, Makito, Shunta Hori, Tomomi Fujii, et al.. (2023). Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin. Japanese Journal of Clinical Oncology. 53(7). 629–632.
9.
Miyake, Makito, Nobutaka Nishimura, Koshiro Nishimoto, et al.. (2023). Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study from experienced institutes. SHILAP Revista de lepidopterología. 4(3). 305–313.
10.
Hori, Shunta, Nobutaka Nishimura, Yasushi Nakai, et al.. (2023). A Low Tacrolimus Concentration-to-Dose Ratio Increases Calcineurin Inhibitor Nephrotoxicity and Cytomegalovirus Infection Risks in Kidney Transplant Recipients: A Single-Center Study in Japan. Transplantation Proceedings. 55(1). 109–115.
11.
Miyake, Makito, Takashi Yoshida, Nobutaka Nishimura, et al.. (2022). A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial. Contemporary Clinical Trials Communications. 26. 100902–100902.
12.
Matsumoto, Kazumasa, Makito Miyake, Nobutaka Nishimura, et al.. (2022). Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer. International Journal of Urology. 29(10). 1195–1203.
13.
Miyake, Makito, Shuichi Morizane, Masashi Honda, et al.. (2022). C‐reactive protein as a prognostic predictor for non‐muscle invasive bladder cancer after intravesical bacillus Calmette‐Guérin therapy: A Japan Urological Oncology Group study analysis. International Journal of Urology. 30(3). 299–307.
14.
Nishimura, Nobutaka, Makito Miyake, Takuto Shimizu, et al.. (2022). First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer. International Journal of Clinical Oncology. 27(11). 1733–1741.
15.
Nishimura, Nobutaka, Makito Miyake, Kota Iida, et al.. (2021). Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy. International Journal of Urology. 29(3). 242–249.
16.
Miyake, Makito, Nobutaka Nishimura, Takashi Inoue, et al.. (2021). Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Trials. 22(1). 136–136.
17.
Hori, Shunta, Nobumichi Tanaka, Tatsuo Yoneda, et al.. (2021). Remnant renal volume can predict prognosis of remnant renal function in kidney transplantation donors: a prospective observational study. BMC Nephrology. 22(1). 367–367.
18.
Nishimura, Nobutaka, Shunta Hori, Makito Miyake, et al.. (2020). Living‐donor kidney transplantation for a patient with hypoparathyroidism, deafness, and renal dysplasia syndrome. SHILAP Revista de lepidopterología. 3(6). 244–247.
19.
Miyake, Makito, Nobutaka Nishimura, Tomomi Fujii, et al.. (2020). Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes. Journal of Endourology. 35(3). 319–327.
20.
Hori, Shunta, Katsuya Aoki, Nobutaka Nishimura, et al.. (2020). <p>Trends in the Treatment Outcomes and Features of Cryptorchidism in Boys: A Single-Institute Experience</p>. Research and Reports in Urology. Volume 12. 373–381.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Zachary Kozel Breakdown of academic impact, for papers by P. Bigot Breakdown of academic impact, for papers by A. Jurczok Breakdown of academic impact, for papers by C. Michiels Breakdown of academic impact, for papers by Rohit Chahal Breakdown of academic impact, for papers by Kyle Rose Breakdown of academic impact, for papers by Joanna Chorbińska Breakdown of academic impact, for papers by Elisabete Barbosa Breakdown of academic impact, for papers by Filippo Sogni Breakdown of academic impact, for papers by Ali̇ Şahi̇n